Nutra Pharma

NPHC · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed · Oct 19, 3:18 PM ET

Prev close $0.0001

About NPHC

Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Plantation, Florida and currently employs 6 full-time employees. The company went IPO on 2001-10-09. The firm's drug candidates include RPI-MN and RPI-78M. RPI-MN is used to treat neurological diseases and autoimmune diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease), Rheumatoid Arthritis (RA) and Myasthenia Gravis. The RPI-78M is used to treat viral diseases, including HIV/AIDS and Herpes. The firm offers Nyloxin/Nyloxin Extra Strength as its over-the-counter (OTC) pain reliever. The company is focused upon marketing homeopathic drugs for the treatment of pain: Nyloxin, Nyloxin Extra Strength Pet Pain, Equine Pain, and Luxury Feet.

Employees: 6
Headquarters: Plantation, Florida
Listed: Oct 9, 2001
Sector: Health Care
Industry: Biotechnology
Website: nutrapharma.com

Leadership

Nutra Pharma executives
Name	Title	Since	Age
Michael Flax	—	2001	69
Dale Vanderputten	—	—	60
Stewart Lonky	—	—	73
Garry Pottruck	—	—	63

Similar companies

Companies in the same industry as Nutra Pharma

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.